Search BRITE hierarchies

Therapeutic category of drugs in Japan [BR:br08301]
  2  Agents affecting individual organs
    21  Cardiovascular agents
      212  Antiarrhythmic agents
        2123  Beta blockers
          D01830  Arotinolol hydrochloride (JP18)

Drug groups [BR:br08330]
  Cardiovascular agent
    DG01466  Adrenergic receptor antagonist
      DG03180  alpha1 and beta-Adrenergic receptor antagonist
        DG01303  Arotinolol
          D01830  Arotinolol hydrochloride
    DG01653  Antiarrhythmics
      DG01806  Class II antiarrhythmic agent
        DG01303  Arotinolol
          D01830  Arotinolol hydrochloride
    DG03231  Antihypertensive
      DG03180  alpha1 and beta-Adrenergic receptor antagonist
        DG01303  Arotinolol
          D01830  Arotinolol hydrochloride

Drug classes [BR:br08332]
  Cardiovascular agent
    DG03231  Antihypertensive
      D01830  Arotinolol hydrochloride
    DG01653  Antiarrhythmics
      D01830  Arotinolol hydrochloride

Target-based classification of drugs [BR:br08310]
  G Protein-coupled receptors
    Rhodopsin family
      Adrenaline
        ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]
          D01830  Arotinolol hydrochloride (JP18) <JP>
        ADRB1 [HSA:153] [KO:K04141]
          D01830  Arotinolol hydrochloride (JP18) <JP>
        ADRB2 [HSA:154] [KO:K04142]
          D01830  Arotinolol hydrochloride (JP18) <JP>

Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
  Chemicals
    D01830  Arotinolol hydrochloride